Pulmonary complications are an extremely common manifestation of primary immunodeficiency disorders (PIDD). Infections are the most common abnormality and can lead to specific pulmonary complications. Patients with PIDD can present with a variety of manifestations such as recurrent bacterial, viral, or fungal pneumonia, bronchiectasis, granulomatous disease, and obstructive or restrictive lung disease. Some of the PIDDs can have unique lung abnormalities seen with specific defects. This review covers the respiratory manifestations seen in patients with a variety of primary immunodeficiencies. This recognition is important to reduce morbidity and mortality in these patients and possibly prevent the occurrence of chronic lung damage.
Al-HerzW, BousfihaA, CasanovaJL, ChapelH, ConleyME, Cunningham-RundlesC, EtzioniA, FischerA, FrancoJL, GehaRS, HammarstromL, NonoyamaS, NotarangeloLD, OchsHD, PuckJM, RoifmanCM, SegerR, TangMLK. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol, 2011; 2:1–26.
4.
ModellV, GeeB, LewisDB, OrangeJS, RoifmanCM, RoutesJM, SorensenRU, NotarangeloLD, ModellF. Global study of primary immunodeficiency diseases (PI)- diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res, 2011; 51:61–70.
5.
AghamohammadiA, C AllahverdiA, AbolhassaniH, MoazzamiK, AlizadehH, GharagozlouM, KalantariN, SajediV, ShafieiA, ParvanehN, MohammadpourM, KarimiN, SadaghianiMS, RezaeiN. Comparison of pulmonary disease in common variable immunodeficiency and X-linked agammaglobulinemia. Respirology, 2010; 15:289–295.
WinkelsteinJA, MarinoMC, LedermanHM, JonesSM, SullivanK, BurksAW, ConleyME, Cunningham-RundlesC, OchsHD. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine, 2006; 85:193–202.
8.
CurtinJJ, WebsterAD, FarrantJ, KatzD. Bronchiectasis in hypogammaglobulinaemia- a computed tomography assessment. Clin Radiol, 1991; 44:82–84.
9.
BonaguraVR, MarchlewshiR, CoxA, RosenthalDW. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol, 2008; 122:210–212.
10.
LucasM, LeeM, LortanJ, Lopez-GranadosE, MisbahS, ChapelH. Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol, 2010; 125:1354–1360.
11.
OrangeJS, GrossmanWJ, NavickisRJ, WilkesMM. Impact of trough IgG on penumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol, 2010; 137:21–30.
12.
KainulainenL, VarpulaM, LiippoK, SvedströmE, NikoskelainenJ, RuuskanenO. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol, 1999; 104:1031–1036.
13.
Cunningham-RundlesC, BodianC. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol, 1999; 92:34–48.
14.
ThickettKM, KumararatneDS, BanerjeeAK, DudleyR, StableforthDE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM, 2002; 95:655–662.
15.
SweinbergSK, WodellRA, GrodofskyMP, GreeneJM, ConleyME. Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol, 1991; 88:96–104.
16.
TorigianDA, LaRosaDF, LevinsonAI, LitzkyLA, MillerWTJr.Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings. J Thorac Imaging, 2008; 23:162–169.
17.
MorimotoY, RoutesJM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep, 2005; 5:370–375.
18.
DaviesCW, JuniperMC, GrayW, GleesonFV, ChapelHM, DaviesRJ. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax, 2000; 55:88–90.
19.
PopaV, JuniperMC, GrayW, GleesonFV, ChapelHM, DaviesRJ. Lymphocytic interstitial pneumonia of common variable immunodeficiency. Ann Allergy, 1988; 60:203–206.
HatabAZ, BallasZK. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol, 2005; 116:1161–1162.
31.
ThatayatikomA, ThatayatikomS, WhiteAJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol, 2005; 95:293–300.
32.
ChaseNM, VerbskyJW, HintermeyerMK, WaukauJK, Tomita-MitchellA, CasperJT, SinghS, ShahirKS, TisolWB, NugentML, RaoRN, MackinnonAC, GoodmanLR, SimpsonPM, RoutesJM. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)J Clin Immunol, 2013; 33:30–39
33.
Cunningham-RundlesC, CooperDL, DuffyTP, StrauchenJ. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol, 2002; 69:171–178.
34.
ResnickES, MoshierEL, GodboldJH, Cunningham-RundlesC. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood, 2012; 119:1650–1657.
35.
ChengYK, DeckerPA, O'ByrneMM, WeilerCR. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol, 2006; 97:306–311.
36.
WolpertJ, KnutsenAP. Natural history of selective antibody deficiency to bacterial polysaccharide antigens in children. Pediatr Asthma Allergy Immunol, 1998; 12:183–191.
37.
KelesidisT, YangO. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol, 2010; 135:347–363.
38.
TarrPE, SnellerMC, MechanicLJ, EconomidesA, EgerCM, StroberW, Cunningham-RundlesC, LuceyDR. Infections in patients with immunodeficiency with thymoma (Good Syndrome). Report of 5 cases and review of the literature. Medicine, 2001; 80:123–133.
PuckJM. The case for newborn screening for severe combined immunodeficiency and related disorders. Ann N Y Acad Sci, 2011; 1246:108–117.
41.
PuckJM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol, 2012; 129:607–616.
42.
DeerojanawongJ, ChangAB, EngPA, RobertsonCF, KempAS. Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome. Pediatr Pulmonol, 1997; 24:324–330.
43.
BoothC, AlgarVE, Xu-BayfordJ, FairbanksL, OwensC, GasparHB. Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency. J Clin Immunol, 2012; 32:449–453.
44.
GrunebaumE, CutzE, RoifmanCM. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency. J Allergy Clin Immunol, 2012; 129:1588–1593.
45.
CareyB, TrapnellBC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol, 2010; 135:223–235.
46.
Martinez-MoczygembaM, HustonDP. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis. Curr Allergy Asthma Rep, 2010; 10:320–325.
47.
KhanA, AgarwalR. Pulmonary alveolar proteinosis. Respir Care, 2011; 56:1016–1028.
ConwayK, GibsonR, PerkinsJ, CunninghamML. Pulmonary agenesis: expansion of the VCFS phenotype. Am J Med Genet, 2002; 113:89–92.
51.
CunninghamML, PerryRJ, EbyPR, GibsonRL, OpheimKE, ManningSC. Primary pulmonary dysgenesis in velocardiofacial syndrome: a second patient. Am J Med Genet A, 2003; 121A:177–179.
52.
FitozS, UçarT, ErdenA, GünlemezA. DiGeorge syndrome associated with left lung aplasia. Br J Radiol, 2001; 74:764–766.
53.
MarkertML, MajureM, HarvilleTO, HulkaG, OldhamK. Severe laryngomalacia and bronchomalacia in DiGeorge syndrome and CHARGE association. Pediatr Pulmonol, 1997; 24:364–369.
54.
WinkelsteinJA, MarinoMC, OchsH, FuleihanR, SchollPR, GehaR, StiehmER, ConleyME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine, 2003; 82:373–384.
55.
AghamohammadiA, ParvanehN, RezaeiN, MoazzamiK, KashefS, AbolhassaniH, ImanzadehA, MohammadiJ, HammarströmL. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol, 2009; 29:769–776.
56.
SegalBH, LetoTL, GallinJI, MalechHL, HollandSM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine, 2000; 79:170–200.
57.
WinkelsteinJA, MarinoMC, JohnstonRBJr, BoyleJ, CurnutteJ, GallinJI, MalechHL, HollandSM, OchsH, QuieP, BuckleyRH, FosterCB, ChanockSJ, DicklerH. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine, 2000; 79:155–169.
58.
MartireB, RondelliR, SoresinaA, PignataC, BroccolettiT, FinocchiA, RossiP, GattornoM, RabusinM, AzzariC, DellepianeRM, PietrograndeMC, TrizzinoA, Di BartolomeoP, MartinoS, CarpinoL, CossuF, LocatelliF, MaccarioR, PieraniP, PuttiMC, StabileA, NotarangeloLD, UgazioAG, PlebaniA, De MattiaD. IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol, 2008; 126:155–164.
59.
AbinunM, WrightC, GouldK, FloodTJ, CassidyJ. Absidia corymbifera in a patient with chronic granulomatous disease. Pediatr Infect Dis J, 2007; 26:1167–1168.
60.
GreenbergDE, GoldbergJB, StockF, MurrayPR, HollandSM, LipumaJJ. Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin Infect Dis, 2009; 48:1577–1579.
61.
LestiniBJ, ChurchJA. Trichosporon pullulans as a complication of chronic granulomatous disease in a patient undergoing immunosuppressive therapy for inflammatory bowel disease. Pediatr Infect Dis J, 2006; 25:87–89.
62.
MailmanTL, SchmidtMH. Francisella philomiragia adenitis and pulmonary nodules in a child with chronic granulomatous disease. Can J Infect Dis Med Microbiol, 2005; 16:245–248.
63.
PastorinoAC, MenezesUP, MarquesHH, ValladaMG, CappelloziVL, CarnideEM, JacobCM. Acremonium kiliense infection in a child with chronic granulomatous disease. Braz J Infect Dis, 2005; 9:529–534.
64.
WynneSM, Kwon-ChungKJ, SheaYR, FilieAC, VarmaA, LupoP, HollandSM. Invasive infection with Trichosporon inkin in 2 siblings with chronic granulomatous disease. J Allergy Clin Immunol, 2004; 114:1418–1424.
